Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01820650 · ClinicalTrials.gov registry record

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

A clinical trial, sponsored by Restor3D.

Terminated
Registry status
359
Enrollment target

NCT01820650: Clinical Trial study, sponsored by Restor3D.

NCT01820650 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 359 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01820650 was terminated before completion, sponsored by Restor3D.

TERMINATED
Registry status
359 participants
Enrollment target

Study Summary

This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.

Interventions

  • DEVICE iTotal G2 CR Knee Replacement System

Trial Details

FieldValue
Enrollment Target 359 participants
Start Date 2013-02
Est. Completion 2023-10
Restor3D

20 total trials

Why NCT01820650 stopped before completion

NCT01820650 is an observational study that tracks outcomes without assigning an intervention. The registered 359 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which iTotal G2 CR Knee Replacement System is the first listed.

NCT01820650 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01820650 about?

NCT01820650 is a clinical study titled "A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System". This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.

What is the current status of trial NCT01820650?

This trial is currently terminated. The enrollment target is 359 participants. The study started on 2013-02. Estimated completion is 2023-10.

What interventions are being tested in trial NCT01820650?

The interventions under investigation include: iTotal G2 CR Knee Replacement System (DEVICE).

Who is sponsoring clinical trial NCT01820650?

This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05118789 · 359 participants · Phase 1

    A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01820650, the US trial registry maintained by the National Library of Medicine. NCT01820650 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.